CA2086259A1 - Traitement topique de l'acne - Google Patents

Traitement topique de l'acne

Info

Publication number
CA2086259A1
CA2086259A1 CA002086259A CA2086259A CA2086259A1 CA 2086259 A1 CA2086259 A1 CA 2086259A1 CA 002086259 A CA002086259 A CA 002086259A CA 2086259 A CA2086259 A CA 2086259A CA 2086259 A1 CA2086259 A1 CA 2086259A1
Authority
CA
Canada
Prior art keywords
carrier
antibiotic
ampicillin
water
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002086259A
Other languages
English (en)
Inventor
Howard N. Robinson
Neil F. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOWSEND MARVIN S
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2086259A1 publication Critical patent/CA2086259A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002086259A 1991-03-05 1992-03-03 Traitement topique de l'acne Abandoned CA2086259A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66479591A 1991-03-05 1991-03-05
US664,795 1991-03-05

Publications (1)

Publication Number Publication Date
CA2086259A1 true CA2086259A1 (fr) 1992-09-06

Family

ID=24667469

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086259A Abandoned CA2086259A1 (fr) 1991-03-05 1992-03-03 Traitement topique de l'acne

Country Status (4)

Country Link
EP (1) EP0536360A4 (fr)
AU (1) AU656097B2 (fr)
CA (1) CA2086259A1 (fr)
WO (1) WO1992015299A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627195A (en) * 1995-04-11 1997-05-06 Massachusetts Eye And Ear Infirmary Treatment for ocular inflammation
EP1603389A1 (fr) * 2003-03-10 2005-12-14 Xantech Pharmaceuticals, Inc. Compositions de desinfection superficielle a performance antimicrobienne amelioree

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
EP0008525A3 (fr) * 1978-08-25 1980-05-28 Beecham Group Plc Compositions pharmaceutiques et procédé pour leur préparation
US4954487A (en) * 1979-01-08 1990-09-04 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
GB8713662D0 (en) * 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives

Also Published As

Publication number Publication date
AU656097B2 (en) 1995-01-19
EP0536360A1 (fr) 1993-04-14
AU1580092A (en) 1992-10-06
WO1992015299A1 (fr) 1992-09-17
EP0536360A4 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
US5260292A (en) Topical treatment of acne with aminopenicillins
US5409917A (en) Topical treatment of acne with cephalosporins
US5505949A (en) Topical treatment for acne
US5837270A (en) Topical anti-acne composition
CA1117012A (fr) Composes pharmaceutiques et dietetiques
US20070122435A1 (en) Topical dapsone for the treatment of acne
MXPA03010022A (es) Composicion que comprende agentes antifungicos para tratar vulvovaginitis y vaginosis.
JP2005239705A (ja) 局所的抗菌性製剤
EP2806868A1 (fr) Compositions antimicrobiennes comprenant dgla, 15-ohepa et/ou 15-hetre et méthodes d'utilisation celles-ci
AU2009244819A1 (en) Proguanil to treat skin/mucosal diseases
KR20050089740A (ko) 주사 치료를 위한 국소적 제형
US20100184727A1 (en) Treatment of excess sebum production
US20030165577A1 (en) Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
WO2008059190A1 (fr) Traitement s'appliquant à laproduction de sébum en excès
US4804530A (en) Anaerobe-selective antibacterial compositions and methods
CA2086259A1 (fr) Traitement topique de l'acne
US20030064103A1 (en) Compositions and methods for treating vulvovaginitis and vaginosis
CA2578121A1 (fr) Utilisation du metronidazole en combinaison avec de l'acide azelaique pour le traitement de la rosacee
JP3568881B2 (ja) 皮膚疾患治療用外用剤
JP3538367B2 (ja) 皮膚組織障害治療・予防・改善用外用剤
EP1686978B1 (fr) Utilisation de l'idrocilamide pour la preparation d'une composition pharmaceutique pour le traitement de la rosacee
CA2325778A1 (fr) Utilisation de 1,1-dioxoperhydro-1,2,4-thiadiazines

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead